Humana Inc.

HUM Healthcare Healthcare Plans

Humana Inc.’s revenue for fiscal 2025 (year ended December 2025) was $129.7 billion, up 10.1% from fiscal 2024. In the quarter to June 2026, revenue grew 26.2%, EPS grew 27.9%, free cash flow grew 58.5% and total debt rose 13.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.

413.16 19.04 −4.41%
Market cap
$51.9B
P/E
38.8×
Fwd P/E
42.9×
Dividend yield
0.86%
F-score
6/9
Altman Z
4.66
Beneish M
−2.29
Dividend safety
61/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

24.34 26.03 18.47 37.30
P/S ratio
0.25 0.24 0.15 0.33
P/FCF ratio
20.14 77.52 16.11 24.18
P/Operating CF
32.23 (18.68) 16.64 24.26
P/B ratio
1.68 1.74 1.12 2.47
EV/Sales
0.18 0.18 0.09 0.26
EV/EBITDA
5.82 6.77 3.97 10.92
EV/FCF
14.38 60.04 9.96 19.30
Current Ratio
2.02 2.00 1.77 1.74
Net Debt/EBITDA
(15.76) 12.27 (4.09) (6.22)
Debt/Equity
0.68 0.70 0.75 0.74
Earnings Yield
4.11% 3.84% 5.42% 2.68%
Free Cash Flow Yield
4.97% 1.29% 6.21% 4.13%
Free Cash Flow per Share
6.95 (15.20) 9.42 15.27
Book value per Share
154.50 147.25 154.95 160.55
Free Cash Flow
836.00 (1,831.00) 1,133.00 1,834.00
EV/EBIT
7.53 8.84 5.28 14.07
Other line items

Show all line items

Columns are period end dates